Carob pod insoluble fiber exerts anti-atherosclerotic effects in rabbits throughsirtuin-1 and peroxisome proliferator-activated receptor-γ coactivator-1α

Journal of Nutrition

Volumn 144, Issue 9, 2014, Pages 1378-1384

  Valero Muñoz, María ^a   Martín Fernández, Beatriz ^a   Ballesteros, Sandra ^a   Lahera, Vicente ^a   de las Heras, Natalia ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; COCONUT OIL; COLLAGEN TYPE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIRTUIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ALGAROBA; AUTACOID; CHOLESTEROL INTAKE; GALACTAN; MANNAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA COACTIVATOR-1; PLANT GUM; TRANSCRIPTION FACTOR; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIATHEROSCLEROTIC ACTIVITY; ARTICLE; CAROB POD INSOLUBLE FIBER; CONTROLLED STUDY; DIETARY FIBER; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL ATHEROSCLEROSIS; EXPERIMENTAL FIBROSIS; MALE; NEW ZEALAND WHITE (RABBIT); NONHUMAN; POD; PROTEIN EXPRESSION; VASCULITIS; ANIMAL; AORTA; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; CHOLESTEROL INTAKE; DIET SUPPLEMENTATION; DRUG EFFECTS; DYSLIPIDEMIAS; FABACEAE; FIBROSIS; FRUIT; INFLAMMATION; LIPID DIET; METABOLISM; PATHOLOGY; PHARMACOLOGY; PLAQUE, ATHEROSCLEROTIC; RABBIT; THERAPEUTIC USE; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DIET, HIGH-FAT; DIETARY FIBER; DIETARY SUPPLEMENTS; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; FABACEAE; FIBROSIS; FRUIT; GALACTANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MANNANS; PLANT GUMS; PLANT OILS; PLAQUE, ATHEROSCLEROTIC; PPAR GAMMA; RABBITS; SIRTUIN 1; TRANSCRIPTION FACTORS; VASODILATION;

EID: 84906895245     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.196113     Document Type: Article

References (47)

1. Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.
2. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
3. Libby P, Aikawa M, Kinlay S, Selwyn A, Ganz P. Lipid lowering improves endothelial functions. Int J Cardiol 2000;74(Suppl 1):S3-10.
4. Ganz P, Creager MA, Fang JC,McConnell MV, Lee RT, Libby P, Selwyn AP. Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis. Am J Med 1996;101:4A10S-16S.
5. Stein S, Lohmann C, Schafer N, Hofmann J, Rohrer L, Besler C, Rothgiesser KM, Becher B, Hottiger MO, Bor´en J, et al. SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J 2010;31:2301-9.
6. Stein S, Schafer N, Breitenstein A, Besler C, Winnik S, Lohmann C, Heinrich K, Brokopp CE, Handschin C, Landmesser U, et al. SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice. Aging (Albany, NY) 2010;2:353-60.
7. Stein S, Matter CM. Protective roles of SIRT1 in atherosclerosis. Cell Cycle 2011;10:640-7.
8. Winnik S, Stein S, Matter CM. SIRT1-an anti-inflammatory pathway at the crossroads between metabolic disease and atherosclerosis. Curr Vasc Pharmacol 2012;10:693-6.
9. Ota H, Eto M, Ogawa S, Iijima K, Akishita M, Ouchi Y. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J Atheroscler Thromb 2010;17:431-5.
10. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, Irani K. SIRT1 promotes endotheliumdependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2007;104:14855-60.
11. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005;434:113-8.
12. Olmos Y, Sanchez-Gomez FJ, Wild B, Garcia-Quintans N, Cabezudo S, Lamas S, Monsalve M. SIRT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1alpha complex. Antioxid Redox Signal 2013;19:1507-21.
13. Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 2006;27:728-35.
14. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005;1:361-70.
15. Valle I, Alvarez-Barrientos A, Arza E, Lamas S, Monsalve M. PGC- 1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res 2005;66:562-73.
16. Kim HJ, Park KG, Yoo EK, Kim YH, Kim YN, Kim HS, Kim HT, Park JY, Lee KU, Jang WG, et al. Effects of PGC-1alpha on TNF-alphainduced MCP-1 and VCAM-1 expression and NF-kappaB activation in human aortic smooth muscle and endothelial cells. Antioxid Redox Signal 2007;9:301-7.
17. Xiong S, Salazar G, Patrushev N, Ma M, Forouzandeh F, Hilenski L, Alexander RW. Peroxisome proliferator-activated receptor gamma coactivator-1alpha is a central negative regulator of vascular senescence. Arterioscler Thromb Vasc Biol 2013;33:988-98.
18. Valero-Muñoz M, Martin-Fernandez B, Ballesteros S, Martinez- Martinez E, Blanco-Rivero J, Balfagon G, Cachofeiro V, Lahera V, de las Heras N. Relevance of vascular PGC-1alpha in molecular alterations in atherosclerosis. Exp Physiol 2013;98:999-1008.
19. The Statistical Division of the Food and Agriculture Organization of the United Nations [database on the Internet]. Updated 2014 Jun 1 [cited 2014 May 1]. Available from: http://faostat.fao.org/site/339/ default.aspx.
20. Wu H, Dwyer KM, Fan Z, Shircore A, Fan J, Dwyer JH. Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study. Am J Clin Nutr 2003;78:1085-91.
21. Glore SR, Van TD, Knehans AW, Guild M. Soluble fiber and serum lipids: a literature review. J Am Diet Assoc 1994;94:425-36.
22. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999;69:30-42.
23. Buil-Cosiales P, Irimia P, Ros E, Riverol M, Gilabert R, Martinez-Vila E, Nunez I, Diez-Espino J, Martinez-Gonzalez MA, Serrano-Martinez M. Dietary fibre intake is inversely associated with carotid intima-media thickness: a cross-sectional assessment in the PREDIMED study. Eur J Clin Nutr 2009;63:1213-9.
24. Zunft HJ, Luder W, Harde A, Haber B, Graubaum HJ, Koebnick C, Grunwald J. Carob pulp preparation rich in insoluble fibre lowers total and LDL cholesterol in hypercholesterolemic patients. Eur J Nutr 2003;42:235-42.
25. Ruiz-Roso B, Quintela JC, de la Fuente E, Haya J, Perez-Olleros L. Insoluble carob fiber rich in polyphenols lowers total and LDL cholesterol in hypercholesterolemic subjects. Plant Foods Hum Nutr 2010;65:50-6.
26. Wu¨rsch P. Influence of tannin-rich carob pod fiber on the cholesterol metabolism in the rat. J Nutr 1979;109:685-92.
27. Gruendel S, Garcia AL, Otto B, Mueller C, Steiniger J, Weickert MO, Speth M, Katz N, Koebnick C. Carob pulp preparation rich in insoluble dietary fiber and polyphenols enhances lipid oxidation and lowers postprandial acylated ghrelin in humans. J Nutr 2006;136: 1533-8.
28. Gruendel S, Garcia AL, Otto B, Wagner K, Bidlingmaier M, Burget L, Weickert MO, Dongowski G, Speth M, Katz N, et al. Increased acylated plasma ghrelin, but improved lipid profiles 24-h after consumption of carob pulp preparation rich in dietary fibre and polyphenols. Br J Nutr 2007;98:1170-7.
29. de las Heras N, Valero-Muñoz M, Ballesteros S, Gomez-Hernandez A, Martin-Fernandez B, Blanco-Rivero J, Cachofeiro V, Benito M, Balfagon G, Lahera V. Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet. Nutr Metab Cardiovasc Dis 2013;23:1107-14.
30. Sanz-Rosa D, Oubina MP, Cediel E, de las Heras N, Aragoncillo P, Balfagon G, Cachofeiro V, Lahera V. Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences. Antioxid Redox Signal 2005;7:1294-301.
31. de las Heras N, Cediel E, Oubina MP, Aragoncillo P, Sanz-Rosa D, Lahera V, Cachofeiro V. Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits. Clin Sci (Lond) 2003;104:357-65.
32. de las Heras N, Aragoncillo P, Maeso R, Vazquez-Perez S, Navarro-Cid J, DeGasparo M, Mann J, Ruilope LM, Cachofeiro V, Lahera V. AT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits. Hypertension 1999;34:969-75.
33. Kaczmarczyk MM, Miller MJ, Freund GG. The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer. Metabolism 2012;61: 1058-66.
34. van Bennekum AM, Nguyen DV, Schulthess G, Hauser H, Phillips MC. Mechanisms of cholesterol-lowering effects of dietary insoluble fibres: relationships with intestinal and hepatic cholesterol parameters. Br J Nutr 2005;94:331-7.
35. Perez-Olleros L, Garcia-Cuevas M, Ruiz-Roso B, Requejo A. Comparative study of natural carob fibre and psyllium husk in rats. Influence on some aspects of nutritional utilisation and lipidaemia. J Sci Food Agric 1999;79:173-8.
36. Chou SY, Chien PJ, Chau CF. Particle size reduction effectively enhances the cholesterol-lowering activities of carrot insoluble fiber and cellulose. J Agric Food Chem 2008;56:10994-8.
37. Andriantsitohaina R, Auger C, Chataigneau T, Etienne-Selloum N, Li H, Martinez MC, Schini-Kerth VB, Laher I. Molecular mechanisms of the cardiovascular protective effects of polyphenols. Br J Nutr 2012;108:1532-49.
38. Elisaf M. Effects of fibrates on serum metabolic parameters. Curr Med Res Opin 2002;18:269-76.
39. Settergren M, Bohm F, Ryden L, Pernow J. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. Eur Heart J 2008;29:1753-60.
40. Aragoncillo P, Maeso R, Vazquez-Perez S, Navarro-Cid J, Ruilope LM, Diaz C, Hernandez G, Lahera V, Cachofeiro V. The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbits. Virchows Arch 2000;437:545-54.
41. Casas-Agustench P, Lopez-Uriarte P, Ros E, Bullo M, Salas-Salvado J. Nuts, hypertension and endothelial function. Nutr Metab Cardiovasc Dis 2011;21(Suppl 1):S21-33.
42. Andersson KE, Hellstrand P. Dietary oats and modulation of atherogenic pathways. Mol Nutr Food Res 2012;56:1003-13.
43. Brandes RP. Activating SIRT1: a new strategy to prevent atherosclerosis? Cardiovasc Res 2008;80:163-4.
44. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:III27-32.
45. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, Alt FW, et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 2007;21:2644-58.
46. Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem 2004;73:417-35.
47. Zhang QJ,Wang Z, Chen HZ, Zhou S, ZhengW, Liu G,Wei YS, Cai H, Liu DP, Liang CC. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 2008;80:191-9.